Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,933 | -17,923 | -8,489 | -37,610 | -29,658 |
| Depreciation Amortization | 1,125 | 1,417 | 288 | 1,217 | 904 |
| Accounts payable and accrued liabilities | 3,496 | 2,813 | 1,174 | -5,298 | -5,682 |
| Other Working Capital | -2,146 | -3,533 | -2,288 | -5,752 | -3,513 |
| Other Operating Activity | 409 | -907 | 283 | 12,413 | 11,153 |
| Operating Cash Flow | $-24,049 | $-18,133 | $-9,032 | $-35,030 | $-26,796 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -29 | -29 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-29 | $-29 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 19,238 | 19,238 | 1,010 | N/A | N/A |
| Debt Repayment | -23,858 | -22,842 | -3,140 | -3,181 | -41 |
| Common Stock Issued | 13,178 | 11,922 | 2,457 | 23,369 | 20,057 |
| Other Financing Activity | 0 | 0 | 6,994 | 0 | 0 |
| Financing Cash Flow | $8,559 | $8,317 | $7,321 | $20,188 | $20,016 |
| Beginning Cash Position | 41,690 | 41,690 | 41,690 | 56,561 | 56,561 |
| End Cash Position | 26,199 | 31,874 | 39,979 | 41,690 | 49,751 |
| Net Cash Flow | $-15,491 | $-9,816 | $-1,711 | $-14,871 | $-6,809 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,049 | -18,133 | -9,032 | -35,030 | -26,796 |
| Capital Expenditure | N/A | N/A | N/A | -29 | -29 |
| Free Cash Flow | -24,049 | -18,133 | -9,032 | -35,059 | -26,825 |